Inhibitory effect of KT3-671, a non-peptide angiotensin subtype 1 receptor antagonist, on sympathetic neurotransmission in isolated rabbit aorta
- PMID: 10675286
- DOI: 10.1006/phrs.1999.0592
Inhibitory effect of KT3-671, a non-peptide angiotensin subtype 1 receptor antagonist, on sympathetic neurotransmission in isolated rabbit aorta
Abstract
Effect of KT3-671 on the sympathetic neurotransmission in isolated rabbit aorta was studied and compared with those of losartan and its active metabolite, EXP3174. Angiotensin (Ang) II (30 n m) produced approximately 1.7-fold increase in the transmural nerve stimulation (TNS)-evoked tritium overflow in the aorta preloaded with [(3)H]noradrenaline. KT3-671 (1 microm) by itself did not alter the TNS-evoked tritium overflow but it (0.1-1 microm) concentration-dependently inhibited the enhancing effect of Ang II on the TNS-evoked tritium overflow. Both losartan (1 and 3 microm) and EXP3174 (0.03-0.3 microm) also inhibited the Ang II effect. KT3-671 was approximately 8.6 and 0.3 times more potent than losartan and EXP3174, respectively, in inhibiting the Ang II response. This is consistent with the previous results showing the relative potency of the three antagonists to block AT(1)receptors. None of Ang II, KT3-671, losartan and EXP3174 affected significantly the spontaneous tritium outflow. These results suggest that KT3-671 as well as losartan and EXP3174 may inhibit vascular sympathetic neurotransmission by blocking presynaptic Ang II subtype 1 receptors, which appears to contribute partly to its antihypertensive action. 2000 Academic Press@p$hr
Copyright 2000 Academic Press.
Similar articles
-
KT3-671, an angiotensin AT1 receptor antagonist, attenuates vascular but not cardiac responses to sympathetic nerve stimulation in pithed rats.J Cardiovasc Pharmacol. 2001 Apr;37(4):427-36. doi: 10.1097/00005344-200104000-00010. J Cardiovasc Pharmacol. 2001. PMID: 11300656
-
No involvement of the AT2-receptor in angiotensin II-enhanced sympathetic transmission in vitro.J Renin Angiotensin Aldosterone Syst. 2003 Jun;4(2):100-5. doi: 10.3317/jraas.2003.009. J Renin Angiotensin Aldosterone Syst. 2003. PMID: 12806592
-
Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP3174: an active metabolite of DuP 753, an orally active antihypertensive agent.J Pharmacol Exp Ther. 1990 Oct;255(1):211-7. J Pharmacol Exp Ther. 1990. PMID: 2213556
-
Discovery of losartan, the first specific non-peptide angiotensin II receptor antagonist.J Hypertens Suppl. 1993 Apr;11(3):S19-22. J Hypertens Suppl. 1993. PMID: 8315513 Review.
-
Activation of a renin-angiotensin system in ischemic cardiac sympathetic nerve endings and its association with norepinephrine release.Int Immunopharmacol. 2002 Dec;2(13-14):1965-73. doi: 10.1016/s1567-5769(02)00148-0. Int Immunopharmacol. 2002. PMID: 12489810 Review.
Cited by
-
The effects of KT3-671, a new angiotensin II (AT 1) receptor blocker in mild to moderate hypertension.Br J Clin Pharmacol. 2003 Nov;56(5):513-9. doi: 10.1046/j.1365-2125.2003.01932.x. Br J Clin Pharmacol. 2003. PMID: 14651725 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous